Formation of anti-DNA-I antibodies in systemic lupus erythematosus: possible mechanism of enzyme function disturbance
https://doi.org/10.14412/1995-4484-2007-690
References
1. <div><p>Исаева J1.A., Левина С.Г., Климов В.Ю.и др. Антителак ДНК, ДНКи ДНК-азная активность плазмыу детей, страдающих системной красной волчанкой. Вопр. ревматизма, 1973, 4, 56-60.</p><p>Климов В.Ю., Левина С.Г., Прозоровская Н.Н.и др. К вопросуо ДНК-азной активности плазмыу детей при системной красной волчанке. Тез. докл. Всесоюзн. конф. детских врачей «Сердечно-сосудистыеи коллагеновые заболевания», М., 1972, 144-145.</p><p>Ревматические болезни. Рук. для врачей. Под ред. В.А Насоновой, Н.В. Бунчука. М., Медицина, 1997, 520 с.</p><p>Демин А.А., Лаптева Г.Ф., Семенова Л.А.и др. Содержание циркулирующих полинуклеотидов, антителк ДНКи ДНК-азная активность крови при волчаночном нефритев клиникеи эксперименте. Уролог, нефрол., 1980, 6,43-44.</p><p>Abe A., Liao Т.Н. The immunological and structural comparisons of deoxyribonucleases I. Glycosylation differences between bovine pancreatic and parotid deoxyribonucleases. J.Biol.Chem., 1983, 258, 17, 10283-10288.</p><p>Tew M.B., Johnson R.W., Reveille J.D. et al. A molecularanalysisofthelowserumdeoxyribonuclease activity in lupus patients. Arthr. Rheum., 2001, 44, 10, 2446-2447.</p><p>Simmonds, M.J., Heward J.M., Kelly M.A. et al. A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves’ disease. Arthr. Rheum., 2002,46, 11,3109-3110.</p><p>Puccetti A., Madaio M.P., Bellese G. et al. AntiDNA antibodies bind to DNase 1. Exp. Med., 1995, 181,5, 1797-1804.</p><p>Sallai K., Nagy E., Derfalvy B. et al. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus assay. Clin. Diagn. Lab. Immunol., 2005, 12,1,56-59.</p><p>Kabsch W., Mannherz H.G., Suck D. et al. Atomic structure of the actin: DNase I complex. Nature, 1990,347,6288,37-44.</p><p>Chen W.J., Lee I-S., Chen C.Y. et al. Biological functions of the disulfides in bovine pancreatic deoxyribonuclease. Protein Sci., 2004, 13,4, 875-883.</p><p>Liao Т.Н., Salnikow J., Moore S. et al. Bovine pancreatic deoxyribonuclease A. Isolation of cyanogen bromide peptides; complete covalent structure of the polypeptide chain. J.Biol.Chem., 1973, 248, 4, 1489-1495.</p><p>Catley B. J., Moore S., Stein W.H. The carbohydrate moiety of bovine pancreatic deoxyribonuclease. J.Biol.Chem.,1969, 244, 4, 933-936.</p><p>Chen C.Y., Lu S.C., Liao Т.Н. The distinctive functions of the two structural calcium atoms in bovine pancreatic deoxyribonuclease. Protein Sci., 2002, 11,3, 659-668.</p><p>Chitrabamrung S., Rubin R.L., Tan E.M. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol.Int., 1981, 1, 2, 55-60.</p><p>Shin H.D., Park B.L., Ют L.H. et al. Common DNASE1 polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum. Mol. Genet., 2004, 13, 20, 2343-2350.</p><p>Gaipl U.S., BeyerT.D., HeyderP. etal. Cooperation between Clq and DNase I in the clearance of necrotic cell-derived chromatin. Arthr. Rheum., 2004, 50, 2, 640-649.</p><p>Yeh T.M., Chang H.C., Liang C.C. et al. Deoxyribonuclease-inhibitory antibodies in systemic lupus erythematosus. J. Biomed. Sci., 2003, 10, 5, 544-551.</p><p>Balada E., Ordi-Ros J., Hemanz S. et al. DNASE I mutation and systemic lupus erythematosus ina Spanish population. Arthr. Rheum., 2002, 46, 7, 1974-1976.</p><p>Verthelyi D., Dybdal N., Elias K.A. et al. DNAse treatment does not improve the survival of lupus prone (NZBxNZW)Fl mice. Lupus, 1998, 7, 4, 223-230.</p><p>Filaci G., Grasso I., Contini P. et al. dsDNA-, nucleohistoneand DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin. Exp. Rheumatol., 1996, 14, 5, 543-550.</p><p>Eichhom G.L., Clark P., Tarien E. The interaction of metal ions with polynucleotides and related compounds. XIII. The effect of metal ions on the enzymatic degradation of ribonucleic acid by bovine pancreatic ribonuclease and of deoxyribonucleic acid by bovine pancreatic deoxyribonuclease I. J.Biol.Chem., 1969, 244, 4, 937-942.</p><p>Ulmer J.S., Herzka A., Toy K.J. et al. Engineering actin-resistant human DNase I for treatment of cystic fibrosis. Proc. Nat. Acad. Sci. USA, 1996, 93, 16, 8225-8229.</p><p>Napirei, М., Karsunsky H., Zevnik B. et al. Features of systemic lupus erythematosus in DNase 1 -deficient mice. Nat. Genet.,2000, 25, 2, 177-181.</p><p>Frost P.G., Lachmann P.J.The relationship of deoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin. Exp. Immunol., 1968, 3, 5, 447-455.</p><p>Gilkeson G.S., Pippen A.M., Pisetsky D.S. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/W mice by immunization with bacterial DNA. J.Clin.Invest., 1995, 95, 2, 1398-1402.</p><p>Hadgiyannaki K., Lachmann P.J. The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB/NZW mice. Clin. Exp. Immunol., 1972,11, 2, 292-295.</p><p>Kunitz M. Crystalline desoxyribonuclease. I. Isolation and general properties. Spectrophotometric method for the measurement of desoxyribonuclease activity. J.Gen.Physiol., 1950,. 33, 4, 349-362.</p><p>Lachmann P.J. Allergic reactions, connective tissue and diseases. Sci. Basis Med. Ann. Rev., 1967, 36-58.</p><p>Lachmann P.J. The in vivo destruction of antigen —a tool for probing and modulating an autoimmune response. Clin. Exp. Immunol., 1996,106, 2, 187-189.</p><p>Lachmann P.J. Lupus and desoxyribonuclease. Lupus, 2003, 12, 3,202-206.</p><p>Lahm A., Suck D. Nase I-induced DNA conformation. 2 A structure ofa DNase I-octamer complex. J. Mol. Biol., 1991, 222, 3, 645-667.</p><p>Lazarides E., Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc. Nat. Acad. Sci. USA, 1974, 71,12, 4742-4746.</p><p>Liebling M.R., Barnett E.V. DNA’ase I inhibition as an indicator of lupus renal disease. Arthr. Rheum., 1975, 18,4,411.</p><p>Macanovic М., Lachmann P.J. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice bya new radial enzyme diffusion assay. Clin. Exp. Immunol., 1997, 108, 2, 220-226.</p><p>Yasutomo K., Horiuchi Т., Kagami S. et al. Mutation of DNASE 1 in people with systemic lupus erythematosus. Nat. Genet., 2001,28, 4, 313-314.</p><p>Pan C. Q., Ulmer J. S., Herzka A. et al. Mutational analysis of human DNase I at the DNA binding interface: Implications for DNA recognition, catalysis, and metal ion dependence. Protein Sci., 1998, 7, 3, 628-636.</p><p>Oefner C., Suck D. Crystallographic refinement and structure of DNase I at 2 A resolution. J. Mol. Biol., 1986, 192, 3, 605-632.</p><p>Paudel H.K., Liao Т.Н. Comparison of the three primary structures of deoxyribonuclease isolated from bovine, ovine, and porcine pancreas. Derivation of the amino acid sequence of ovine DNase and revision of the previously published amino acid sequence of bovine DNase. J.Biol.Chem., 1986, 261, 34, 16012-16017.</p><p>Prince W.S., Baker D.L., Dodge A.H. et al. Pharmacodynamics of recombinant human DNase I in serum. Clin. Exp. Immunol., 1998,113, 2, 289-296.</p><p>Yasuda T, Nadano D, Tanaka Y, et al. Practical utility of an antibody specific toa synthetic peptide corresponding to the N-terminal amino acid sequence of human urine DNAse I for genetic analysis of human DNase I isozymes. Biochem. Int., 1990, 22,4, 699-705.</p><p>Price P.A, Characterization of Ca++ and Mg++ binding to bovine pancreatic deoxyribonuclease A. J.Biol.Chem., 1972, 247, 9, 2895-2899.</p><p>Price P.A., Liu T.Y., Stein W.H. et al. Properties of chromatographically purified bovine pancreatic deoxyibonuclease A. J.BioLChem., 1969, 244, 4, 917-923.</p><p>Klinman D.M., Shirai A., Ishigatsubo Y. et al. Quantitation of IgMand IgG-secreting В cells in the peripheral blood of patients with SLE. Arthr. Rheum., 1991, 34, 3, 1404-1410.</p><p>Yanase K., Smith R.M., Puccetti A. et al. Receptormediated cellular entry of nuclear localizing antiDNA antibodies via myosin 1. J. Clin. Invest., 1997, 100, 1,25-31,</p><p>Davis J.C. Jr., Manzi S., Yarboro C. et al. Recombinant human DNase I (rhDNase) inpatients with lupus nephritis. Lupus, 1999, 8, 1,68-76.</p><p>ShakS.,Capon D.J., Hellmiss R. etal. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc. Nat. Acad. Sci. USA, 1990, 87, 2, 917-923.</p><p>Salnikow J., Moore S., Stein W,H. Comparison of the multiple forms of bovine pancreatic deoxyribonuclease. J.Biol.Chem., 1970, 245, 21, 5685-5690.</p><p>Feng X.B., Shen N., Qian J. et al. Single nucleotide polymorphisms of deoxyribonuclease I and their expression in Chinese systemic lupus erythematosus patients. Chin. Med. J., 2004,117, 11,1670-1676.</p><p>Madaio M.P., Fabbi М., Tiso M. et al. Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur. J. Immunol., 1996, 26, 12, 3035-3041.</p><p>Suck D., Oefner C., Kabsch W. Three-dimensional structure of bovine pancreatic DNase I at 2.5 A resolution. EMBO J., 1984, 3, 10, 2423-2430.</p><p>Suck D. DNA recognition by DNase I. J. Mol. Recognit., 1994, 7, 2,65-70.</p><p>Fredriksen K., Osei A., Sundsfjord A. et al. Systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus В К in lupus prone (NZB/W) FI hybrids, but not in normal mice. Eur. J.Immunol., 1994, 24, 1, 66-70.</p><p>Chakraborty P., Kacem H.H., Makni-Karray K. et al. The A/T mutation in exon 2 of the DNASE I gene is not present in Tunisian patients with systemic lupus erythematosus or in healthy subjects. Arthr. Rheum., 2003, 48, 11, 3297-3298.</p><p>Macanovic М., Sinicropi D., Shak S. et al. The treatment of systemic lupus erythematosus (SLE) in NZB/W FI hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin. Exp. Immunol., 1996,106, 2, 243-252.</p><p>Walport M.J. Lupus, DNase and defective disposal of cellular debris. Nat. Genet., 2000, 25, 2, 135-136.</p><p>Yasutomo K. Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology, 2003,42, 2,214-222.</p></div><br />
Review
For citations:
Zborovskaya I.A., Trofimenco A.C., Gontar L.P. Formation of anti-DNA-I antibodies in systemic lupus erythematosus: possible mechanism of enzyme function disturbance. Rheumatology Science and Practice. 2007;45(3):59-63. (In Russ.) https://doi.org/10.14412/1995-4484-2007-690